Healthcare Industry Live Attenuated Vaccines Market Trends, 2021 | Page 2

Your Catalyst To a Lucrative Business
It has been anticipated that an advanced live attenuated vaccine may soon gain the potential to prevent a
disease. Moreover, they can also be utilized for therapeutic purposes of an existing disease. Market size on
the basis of types spans Measles, Polio, Smallpox, Rotavirus, Tuberculosis, Yellow fever, Varicella zoster, and
Others. Market size on the basis of End Users spans hospitals clinics, and healthcare research institutes.
Market size on the basis of product type spans Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP,
Polio, and MMR. Among all, the segment of pneumococcal disease is projected to take over the greatest
share of the market globally, the reason being augmented occurrence of pneumococcal infect ions and the
prerequisite for immunizations to avert the frequency of disease. Market size on the basis of application
spans Pediatric, and Adult.
Market size on the basis of geographical region spans North America, China, Europe, Japan, India, and
Southeast Asia. As far as the geography is concerned, North America is the one that is dominating the market
and is also simultaneously accounting for the largest share in the market. Major companies operating in the
global live attenuated vaccines market include Astellas Pharma Inc, MedImmune, LLC, Merck & Co, Pfizer,
Sanofi Pasteur, Serum Institute, India Pvt. Ltd., GlaxoSmithKline, Johnson & Johnson, CSL Limited, and
Emergent BioSolutions, Inc.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-
category/pharmaceuticals-industry
Follow Us: